Type 2 diabetes (T2D) is estimated to affect approximately 439 million individuals by year 2030 worldwide\[[@ref1]\]. It is associated with significant morbidity and mortality due to cardiovascular complications\[[@ref2]\]. South East Asian countries account highest burden of diabetes, including India which may have up to 33 million cases\[[@ref3]\]. Cardiovascular disease (CVD) is more prevalennt in patient with type 2 diabetes than general population\[[@ref4]\]. Dyslipidemia is a well known risk factor for CVD, with respect to type 2 diabetes and it affects almost 50% of population\[[@ref5]\]. The characteristic features of dyslipidemia are high plasma triglyceride concentration, low high-density lipoprotein (HDL) cholesterol concentration and increased concentration of small dense low-density lipoprotein (LDL) cholesterol particle\[[@ref6]\]. The elevated level of LDL is the characteristic marker for CVD\[[@ref7]\]. Although there is considerable evidence that abnormalities in serum lipids and lipid metabolism are major risk factors for increased incidence of CVD in type 2 diabetes, the relative role of various lipoprotein abnormalities in determining the risk in diabetic individuals needs to be addressed\[[@ref8]\].

In view of the predisposition for the development of atherosclerotic vascular disease in diabetics, attention has been focused on abnormalities of lipid and lipoprotein metabolism in diabetes. The aim of the present work was to study pattern, and severity of lipid disorders among type 2 diabetic patients especially in urban rural region of Pune, Maharashtra, India.

Total of 99 (45 males and 54 females) type 2 diabetic subjects attending the OPD of Bharati Medical Hospital and 101 (43 males and 58 females) controls were included in the study. Subjects with HIV/HBsAg, bodily injuries, surgical procedures in recent past, underweight (BMI=18.5) and alcoholics were excluded. The purpose of the study was explained to all potential subjects and only those who gave informed written consent were included in the study. The anthropometric measurements like height, weight, BMI, waist circumference, hip circumference were recorded for all the subjects. Blood pressure was measured using standard mercury sphygmomanometer after patient had rested for at least 10 min. About 8 ml venous blood samples, after at least 8 h fasting, were collected from all subjects by vain puncture, in plain and EDTA vacutainers.

A standard dietary and physical activity questionnaire was delivered to all the subjects. The ongoing prescribed drugs, their dosages and other co-morbidities, if any were recorded for all diabetic subjects. The present study was undertaken after ethical approval from the Institutional Human Ethical Committee (BVDU/MC/2 dated 27th February 2012).

Glucose, total cholesterol (TC), triglycerides (TG), high density lipoprotein cholesterol (HDL-C), low density lipoprotein cholesterol (LDL-C) were estimated using commercial kits (Coral clinical system, Goa, India). Very low density lipoprotein cholesterol (VLDL-C) was estimated by using the formula: triglycerides/5. Risk ratios for all the samples were calculated by dividing TC by HDL-C.

The lipid profiles from the subjects were classified as per the guidelines of National Cholesterol Education Programme (NCEP) Adult Treatment Panel III (ATP III). The NCEP-ATPIII guidelines classify hypercholesterolemia when TC\>200 mg/dl, high LDL-C if LDL-C\>100 mg/dl, hypertriglyceridemia if TG\>150 mg/dl and low HDL-C if the value is \<40 mg/dl. The subjects with one or more abnormal lipid concentrations were considered dyslipidemic. Type 2 diabetes mellitus was defined as per the American Diabetes Association (ADA) criteria. The data obtained from the study were analyzed by GraphPad 13.0 (Trial Version). Pearson\'s correlation test was performed to examine various correlations. Two tailed unpaired t-test was used to compare means of different parameters. The differences among the means were considered significant if *P*≤0.05. All the values were represented as mg/dl unless otherwise specified.

The present study included 99 (45 males and 54 females) type 2 diabetic subjects and 101 (43 males and 58 females) healthy controls. The mean age of diabetic and control subjects was 51.82±0.63 and 50.50±0.61 years, respectively.

[Table 1](#T1){ref-type="table"} shows lipid profiles of subjects and its classification based on ATPIII for total cholesterol, triacylglycerols, LDL-C and HDL-C levels. The lower HDL-C (97%) and higher TC (15%) was observed in diabetic groups as compared to healthy controls. [Table 2](#T2){ref-type="table"} summarizes the FPG, lipid parameters, and risk ratio for the study population.
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Highly significant differences were observed in the FPG, TC, HDL-C, LDL-C and risk ratios in diabetics as compared to control. The values reported in the present study are contradictory with the earlier reports indicating higher levels of LDL-C in the diabetic population\[[@ref9]\]. In the present study, the LDL-C values were significantly lower in the diabetic group owing to the statin treatments. The imbalance in the lipid profiles in the diabetic subjects is shown to be highly dependent upon medicines and glycemic control\[[@ref10][@ref11][@ref12]\]. The lower HDL-C among diabetic people attending primary care is now well-recognized\[[@ref13]\]. In the present study, out of the diabetic people with lower than recommended HDL-C levels, about 45.36% had either hypertension, ischemic heart disease or other forms of cardiovascular disorders. The lower than normal HDL-C is reported to be a highly prevalent and potentially modifiable risk factor for CVD prevention in type 2 diabetes\[[@ref13]\]. The current guidelines suggest aggressive treatment modalities to reduce LDL cholesterol, blood pressure and glucose levels in diabetic patients, but data concerning the management of low HDL cholesterol levels is still inconclusive\[[@ref14]\]. Hypercholesterolemia and low HDL levels observed in the present study in diabetic population are well known risk factors for cardiovascular diseases. It has been reported that normalizing low HDL-C in primary care diabetic patients would decrease the estimated CVD mortality by 42% in women and 23% in men\[[@ref13]\].

The present study also reported significantly different correlation of FPG with lipid parameters in diabetic subjects as compared to healthy volunteers ([Table 3](#T3){ref-type="table"}, [fig. 1](#F1){ref-type="fig"}). The relationship among FPG and lipid variables was observed to be different in healthy and diabetic population. The FPG and TG were found to be significantly correlated in diabetic population (*P*=0.0236). The negatively correlated HDL-C and LDL-C showed a positive and significant correlation with FPG in diabetic subjects (*P*=0.0443 and *P*=0.0405, respectively). The positive correlations of FPG with VLDL-C and TC were enhanced in diabetic population with higher probability of FPG modifying the VLDL and TC contents. Also, FPG was found to be the predictor for hypercholesterolemia (R^2^=0.075), HDL-C and LDL-C contents (R^2^=0.011) and TG and VLDL (R^2^=0.047) (*P*≤0.05 for all regression analyses).
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CORRELATION BETWEEN FPG AND VARIOUS LIPID PARAMETERS IN HEALTHY AND DIABETIC INDIVIDUALS
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![Correlations between FPG and various lipid parameters in diabetic population from the present study.\
(a) Cholesterol (R^2^=0.075), (b) tryglycerides (R^2^=0.0478), (c) HDL-C and LDL-C (R^2^=0.011), (d) VLDL (R^2^=0.047), (e) WHR and risk ratio (R^2^=0.0654).](IJPhS-77-630-g004){#F1}

The present study indicates the need for prescribing a non-statin HDL cholesterol--raising medication to diabetic people to decrease their predisposition to CVD. In addition, the altered pattern of correlation of various lipid parameters with FPG and its potential as a predictor of dyslipidemia in diabetics, points to the much stressed necessity of good glycemic control.
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